The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
RNA m6A modification and its function in diseases
Open accessAbstract
N 6 -methyladenosine (m 6 A) is the most common post-transcriptional RNA modification throughout the transcriptome, affecting fundamental aspects of RNA metabolism. m 6 A modification could be installed by m 6 A “writers” composed of core catalytic components (METTL3/METTL14/WTAP) and newly defined regulators and removed by m 6 A “erasers” (FTO and ALKBH5). The function of m 6 A is executed by m 6 A “readers” that bind to m 6 A directly (YTH domain-containing proteins, eIF3 and IGF2BPs) or indirectly (HNRNPA2B1). In the past few years, advances in m 6 A modulators (“writers,” “erasers,” and “readers”) have remarkably renewed our understanding of the function and regulation of m 6 A in different cells under normal or disease conditions. However, the mechanism and the regulatory network of m 6 A are still largely unknown. Moreover, investigations of the m 6 A physiological roles in human diseases are limited. In this review, we summarize the recent advances in m 6 A research and highlight the functional relevance and importance of m 6 A modification in in vitro cell lines, in physiological contexts, and in cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The increases in m6A are also consistent with the observed increase in the m6A writer, METTL3, and decrease in m6A eraser, ALKBH5 (Tong et al., 2018).”
From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Tong et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Meyer, K. D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C. E., & Jaffrey, S. R. (2012) · Cell · doi:10.1016/j.cell.2012.05.003 · Cited by 4,223
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
Ping, X.-L., Sun, B.-F., Wang, L., Xiao, W., Yang, X., Wang, W.-J., Adhikari, S., Shi, Y., Lv, Y., Chen, Y.-S., et al. (2014) · Cell Research · doi:10.1038/cr.2014.3 · Cited by 2,375
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Xiao, W., Adhikari, S., Dahal, U., Chen, Y.-S., Hao, Y.-J., Sun, B.-F., Sun, H.-Y., Li, A., Ping, X.-L., Lai, W.-Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.012 · Cited by 2,054
Cited by
Sorted by citations
Zhang, B., Wu, Q., Li, B., Wang, D., Wang, L., & Zhou, Y. L. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01170-0 · Cited by 940
Wang, Q., Chen, C., Ding, Q., Zhao, Y. Q., Wang, Z., Chen, J., Jiang, Z., Zhang, Y., Xu, G., Zhang, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319639 · Cited by 861
Chen, X., Xu, M., Xu, X., Zeng, K., Liu, X., Pan, B., Li, C., Sun, L., Qin, J., Xu, T., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01220-7 · Cited by 407
Role of m6A RNA methylation in cardiovascular disease (Review)
Qin, Y., Li, L., Luo, E., Hou, J., Yan, G., Wang, D., Qiao, Y., & Tang, C. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4746 · Cited by 328
Wang, M., Liu, J., Zhao, Y., He, R., Xu, X., Guo, X., Xu, L., Xu, S., Miao, J., Guo, J., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01249-8 · Cited by 267
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
Wang, H., Xu, B., & Shi, J. (2019) · Gene · doi:10.1016/j.gene.2019.144076 · Cited by 220
Naturally occurring modified ribonucleosides
McCown, P. J., Ruszkowska, A., Kunkler, C. N., Breger, K., Hulewicz, J. P., Wang, M. C., Springer, N. A., & Brown, J. A. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1595 · Cited by 219
Pooled CRISPR screening identifies m 6 A as a positive regulator of macrophage activation
Tong, J., Wang, X., Liu, Y., Ren, X., Wang, A. M., Chen, Z., Yao, J., Mao, K., Liu, T., Meng, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd4742 · Cited by 202
Self-citationMETTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy
Jiang, L., Liu, X., Hu, X.-R., Gao, L., Zeng, H.-X., Wang, X., Huang, Y., Zhu, W., Wang, J., Wen, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.002 · Cited by 194
m 6 A demethylase ALKBH5 controls CD4 + T cell pathogenicity and promotes autoimmunity
Zhou, J., Zhang, X., Hu, J., Qu, R., Yu, Z., Xu, H. Y., Chen, H., Yan, L., Ding, C., Zou, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg0470 · Cited by 191
Self-citationMETTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-κB Signaling Pathway
Wang, J., Yan, S., Lu, H., Wang, S., & Xu, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/3120391 · Cited by 186
m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
Liu, L., Wang, J., Sun, G., Wu, Q., Ma, J., Zhang, X., Huang, N. J., Bian, Z., Gu, S., Xu, M., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1119-7 · Cited by 186
Malacrida, A., Rivara, M., Domizio, A. D., Cislaghi, G., Miloso, M., Zuliani, V., & Nicolini, G. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115300 · Cited by 178
Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
Jiang, L., Lin, W., Zhang, C., Ash, P. E. A., Verma, M., Kwan, J., van Vliet, E., Yang, Z., Cruz, A. L., Boudeau, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.038 · Cited by 177
Self-citationHaruehanroengra, P., Zheng, Y. Y., Zhou, Y., Huang, Y., & Sheng, J. (2020) · RNA Biology · doi:10.1080/15476286.2020.1722449 · Cited by 178
Zhou, H., Shen, X., Chen, Y., Wu, X., Ma, Z., Tan, Z., Wang, J., Li, Y., Liu, J., Duan, A., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03005-9 · Cited by 170
IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
Pu, J., Wang, J., Qin, Z., Wang, A., Zhang, Y., Wu, X., Wu, Y. M., Li, W., Xu, Z., Lu, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578816 · Cited by 156
Hao, L., Wang, J., Liu, B.-Q., Yan, J. Y., Li, C., Jiang, J., Zhao, F.-Y., Qiao, H.-Y., & Wang, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118878 · Cited by 152
Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Guan, Q., Lin, H., Miao, L., Guo, H., Chen, Y., Zhuo, Z., & He, J. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01231-5 · Cited by 155
Function and evolution of RNA N6-methyladenosine modification
Zhu, Z., Huo, F., & Pei, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45231 · Cited by 136
YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA
Zhang, Z., Wang, Q., Zhao, X., Shao, L., Liu, G., Zheng, X., Xie, L., Zhang, Y., Sun, C., & Xu, R. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03186-2 · Cited by 135
Liu, Q., Li, M., Jiang, L., Jiang, R., & Fu, B. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.168 · Cited by 134
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
Yang, D.-D., Chen, Z., Yu, K., Lu, J., Wu, Q.-N., Wang, Y., Ju, H., Xu, R., Liu, Z., & Zeng, Z.-L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00115 · Cited by 126
Guo, M., Yan, R., Ji, Q., Yao, H., Sun, M., Duan, L., Xue, Z., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106800 · Cited by 121
Ma, L., Xue, X., Zhang, X., Yu, K., Xu, X., Tian, X., Miao, Y., Meng, F., Liu, X., Guo, S., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02200-5 · Cited by 113
Si, W., Li, Y., Ye, S., Li, Z., Liu, Y., Kuang, W., Chen, D., & Zhu, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00103 · Cited by 111
Liu, B.-H., Tu, Y., Ni, G.-X., Yan, J., Yue, L., Li, Z.-L., Wu, J., Cao, Y., Wan, Z.-Y., Sun, W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667644 · Cited by 110
Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
Zheng, W., Dong, X., Zhao, Y. Q., Wang, S., Jiang, H., Zhang, M., Zheng, X., & Gu, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01403 · Cited by 100
Emerging role of m6A RNA methylation in nutritional physiology and metabolism
Wu, J., Frazier, K., Zhang, J., Gan, Z., Wang, T., & Zhong, X. (2019) · Obesity Reviews · doi:10.1111/obr.12942 · Cited by 98
Zheng, L., Tang, X., Lu, M., Sun, S., Xie, S., Cai, J., & Zan, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106937 · Cited by 97
Huang, X., Lv, D., Yang, X. Y., Li, M., & Zhang, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15848 · Cited by 95
The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression
Liu, S., Li, Q., Chen, K., Zhang, Q., Li, G., Zhuo, L., Zhai, B., Sui, X., Hu, X., & Xie, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110098 · Cited by 90
Barros‐Silva, D., Lobo, J., Guimarães‐Teixeira, C., Carneiro, I. C., Oliveira, J., Martens‐Uzunova, E. S., Henrique, R., & Jerónimo, C. (2020) · Cancers · doi:10.3390/cancers12040771 · Cited by 85
He, Y., Xing, J., Wang, S., Xin, S., Han, Y., & Zhang, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.65 · Cited by 81
Potential roles of N6-methyladenosine (m6A) in immune cells
Liu, C., Yang, Z., Li, R., Wu, Y., Chi, M., Gao, S., Sun, X., Meng, X., & Wang, B. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02918-y · Cited by 80
The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases
Wang, Y., Li, L., Li, J., Zhao, B., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.755691 · Cited by 81
Li, H., Huang, G., Tu, J., Lv, D., Jin, Q., Chen, J.-K., Zou, Y., Lee, D., Shen, J., & Xie, X. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104142 · Cited by 80
Self-citationCong, P., Wu, T., Huang, X., Liang, H., Gao, X., Li, T., Li, W., Chen, A., Wan, H., He, M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709022 · Cited by 80
Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Ni, H.-H., Zhang, L., Huang, H., Dai, S., & Li, J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02553-z · Cited by 77
Dai, B., Sun, F., Cai, X., Li, C., Liu, H., & Shang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.634162 · Cited by 77
Sang, W., Xue, S., Jiang, Y., Lu, H., Zhu, L., Wang, C., & Ma, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119528 · Cited by 75
Long Non-Coding RNA Epigenetics
Kazimierczyk, M., & Wrzesiński, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116166 · Cited by 78
Lin, Y., Wei, X., Jian, Z., & Zhang, X. (2020) · Cancer Medicine · doi:10.1002/cam4.2918 · Cited by 73
Ge, P., Duan, H., Tao, C., Niu, S., Hu, Y., Duan, R., Shen, A., Sun, Y., & Sun, W. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s399480 · Cited by 76
Hofmann, M.-C. C., & McBeath, E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.897062 · Cited by 71
Wang, Y., Mao, J., Wang, X., Lin, Y., Hou, G., Zhu, J., & Xie, B. (2019) · Epigenomics · doi:10.2217/epi-2019-0002 · Cited by 63
Li, F., Wang, H., Huang, H., Zhang, L., Wang, D., & Wan, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00994 · Cited by 61
Structures and target RNA preferences of the RNA-binding protein family of IGF2BPs: An overview
Korn, S. M., Ulshöfer, C. J., Schneider, T. P., & Schlundt, A. (2021) · Structure · doi:10.1016/j.str.2021.05.001 · Cited by 60
Wang, Y., Li, H., Zhang, Y., Jiang, R.-X., Xu, J., Gu, J., Jiang, Z., Jiang, Z., You, Q., & Guo, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01374 · Cited by 61
Self-citationWolf, D. A., Lin, Y., Duan, H., & Cheng, Y. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa018 · Cited by 59
Zhou, W., Wang, X., Chang, J., Cheng, C., & Miao, C. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.2002256 · Cited by 58
Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis
Wang, Q., Zhang, H., Chen, Q., Wan, Z., Gao, X., & Qian, W. (2019) · Disease Markers · doi:10.1155/2019/5648783 · Cited by 58
Resveratrol Attenuates Aflatoxin B1-Induced ROS Formation and Increase of m6A RNA Methylation
Wu, J., Gan, Z., Zhuo, R., Zhang, L., Wang, T. Z., & Zhong, X. (2020) · Animals · doi:10.3390/ani10040677 · Cited by 58
Li, J., Pei, Y., Zhou, R., Tang, Z., & Yang, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56251 · Cited by 55
Liu, B., Ao, S., Tan, F., Ma, W., Liu, H., Liang, H., Yang, X., & Chi, X. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-845 · Cited by 52
Yang, K., Zhao, Y., Hu, J., Gao, R., Shi, J., Wei, X., Chen, J., Hu, K., Sun, A., & Ge, J. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.09.004 · Cited by 52
Du, Q., Huo, F., Du, W.-Q., Sun, X., Jiang, X. J., Zhang, L.-S., & Pei, D. (2022) · Oncogene · doi:10.1038/s41388-022-02435-2 · Cited by 51
N 6 ‐methyladenosine (m 6 A) RNA modification in human cancer
Huo, F., Zhu, Z., & Pei, D. (2020) · Cell Proliferation · doi:10.1111/cpr.12921 · Cited by 50
RNA Biology Provides New Therapeutic Targets for Human Disease
Harries, L. W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00205 · Cited by 53
Recent developments of small molecules targeting RNA m6A modulators
Gu, J., Xu, J. Q., You, Q., & Guo, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112325 · Cited by 47
Insights into roles of METTL14 in tumors
Liu, X., Du, Y., Huang, Z., Qin, H., Chen, J., & Zhao, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.13168 · Cited by 47
TGF-β signaling promotes cervical cancer metastasis via CDR1as
Zhong, G., Zhao, Q., Chen, Z., & Yao, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01743-9 · Cited by 47
Biochemical and structural basis for YTH domain of human YTHDC1 binding to methylated adenine in DNA
Woodcock, C. B., Horton, J. R., Zhou, J., Bedford, M. T., Blumenthal, R., Zhang, X., & Cheng, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa604 · Cited by 47
Jin, Y., Qiu, J., Lu, X., Ma, Y., & Li, G. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.027815 · Cited by 46
mRNA Metabolism in Cardiac Development and Disease: Life After Transcription
Gao, C., & Wang, Y. (2019) · Physiological Reviews · doi:10.1152/physrev.00007.2019 · Cited by 44
Wang, Y.-J., Yang, B., Lai, Q., Shi, J., Peng, J., Zhang, Y., Hu, K., Li, Y., Peng, J.-W., Yang, Z.-Z., et al. (2020) · RNA Biology · doi:10.1080/15476286.2020.1804697 · Cited by 45
Multiple Functions of RNA Methylation in T Cells: A Review
Chao, Y., Li, H., & Zhou, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627455 · Cited by 43
Self-citationWu, H., Li, F., & Zhu, R. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa170 · Cited by 42
Wang, H., Wei, W., Zhang, Z., Liu, Y., Shi, B., Zhong, W., Zhang, H.-S., Fang, X., Sun, C., Wang, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04459-0 · Cited by 41
N6‑methyladenine RNA modification and cancer (Review)
Jun, Y., Chen, J., Fei, X., Wang, X., & Wang, K. (2020) · Oncology Letters · doi:10.3892/ol.2020.11739 · Cited by 41
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Li, J., Dai, Y., Wu, L., Zhang, M., Ouyang, W., Huang, J., & Chen, S. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0821-6 · Cited by 44
N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4
van den Homberg, D. A. L., van der Kwast, R. V. C. T., Quax, P. H. A., & Nossent, A. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031057 · Cited by 41
Guo, W., Zhang, C., Feng, P., Li, M., Wang, X., Xia, Y., Chen, D., & Li, J. (2021) · Oncogene · doi:10.1038/s41388-021-01987-z · Cited by 39
He, S., Li, W., Wang, G., Wang, X., Fan, W., Zhang, Z., Li, N., & Hou, S. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.09.008 · Cited by 39
Li, Q., Wang, Y., Meng, X., Wang, W., Duan, F., Chen, S., Zhang, Y., Sheng, Z., Gao, Y., & Zhou, L. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05146-x · Cited by 39
Involvement of YTHDF1 in renal fibrosis progression via up‐regulating YAP
Xing, J., He, Y., Wang, K., Wan, P., & Zhai, X. (2022) · The FASEB Journal · doi:10.1096/fj.202100172rr · Cited by 38
The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity
Tong, J., Zhang, W., Chen, Y., Yuan, Q., Qin, N.-N., & Qu, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.845625 · Cited by 37
Self-citationFat mass and obesity–associated protein promotes liver steatosis by targeting PPARα
Wei, X., Zhang, J., Tang, M. M., Wang, X., Fan, N., & Peng, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01640-y · Cited by 39
Wu, X., Zhang, X., Tao, L., Dai, X., & Chen, P. (2020) · BioMed Research International · doi:10.1155/2020/2053902 · Cited by 36
Wang, Y., Chen, Y., Liang, J., Jiang, M., Zhang, T., Wan, X., Wu, J., Li, X., Chen, J., Sun, J., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad005 · Cited by 35
Dong, L., Geng, Z., Liu, Z., Tao, M., Pan, M., & Lu, X. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153550 · Cited by 35
Holmes, M. J., Padgett, L. R., Bastos, M. S. E., & Sullivan, W. J. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009335 · Cited by 32
METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury
Li, W., Tan, M., Wang, H., Wang, Z., Pang, Y., Yang, R., Zhong, S., Pan, X., Chen, S., Wang, Q., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121887 · Cited by 34
The role m6A RNA methylation is CNS development and glioma pathogenesis
Pan, T., Wu, F., Li, L., Wu, S., Zhou, F., Zhang, P., Sun, C., & Xia, L. (2021) · Molecular Brain · doi:10.1186/s13041-021-00831-5 · Cited by 34
Bo, C., Li, N., Li, H., Zhang, S., & An, Y. (2021) · Human Cell · doi:10.1007/s13577-021-00608-x · Cited by 34
Self-citationJiang, W., Zhu, P., Huang, F., Zhao, Z., Zhang, T., An, X., Liao, F., Guo, L., Liu, Y., Zhou, N., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720925 · Cited by 33
Xiao, P., Meng, Q., Liu, Q., Lang, Q., Yin, Z., Li, G., Li, Z., Xu, Y., Yu, Z., Geng, Q., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216075 · Cited by 33
Epigenetic regulation of N6‐methyladenosine modifications in obesity
Sun, M., & Zhang, X. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13571 · Cited by 32
The regulatory role of N6 ‐methyladenosine modification in the interaction between host and microbes
Zhuo, R., Xu, M., Wang, X., Zhou, B., Wu, X., Leone, V., Chang, E. B., & Zhong, X. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1725 · Cited by 31
Research progress on N6-adenosylate methylation RNA modification in heart failure remodeling
Yang, Y., Mbikyo, M. B., Zhang, J., Sun, Y., & Li, Z. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0025 · Cited by 32
Liu, L., Zeng, S., Jiang, H., Zhang, Y., Guo, X., & Wang, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.043 · Cited by 32
Lin, Z., Jiang, T., Zheng, W., Zhang, J., Li, A., Lu, C., & Liu, W. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01228-8 · Cited by 31
Li, L., Tang, Q., Ge, J., Wang, D., Mo, Y., Zhang, Y., Wang, Y., Xiong, F., Yan, Q., Liao, Q., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1766 · Cited by 30
Liu, Z., Liu, N., Huang, Z., & Wang, W. (2020) · Cancer Management and Research · doi:10.2147/cmar.s284273 · Cited by 30
Pan, Y., Xiao, K., Li, Y., Li, Y., & Liu, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.632934 · Cited by 32
The occurrence order and cross-talk of different tRNA modifications
Li, J., Zhu, W., Yang, W., Li, C., & Liu, R. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1906-4 · Cited by 31
Nuclear innate sensors for nucleic acids in immunity and inflammation
Lin, H., & Cao, X. (2020) · Immunological Reviews · doi:10.1111/imr.12893 · Cited by 29
Fang, J., Hu, M., Sun, Y., Zhou, S., & Li, H. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5767 · Cited by 29
Self-citationGenomic Insights into Molecular Regulation Mechanisms of Intramuscular Fat Deposition in Chicken
Cao, Y., Xing, Y., Guan, H., Ma, C., Jia, Q., Tian, W., Li, G., Tian, Y., Kang, X., Liu, X., et al. (2023) · Genes · doi:10.3390/genes14122197 · Cited by 28
Self-citationA Role for N6-Methyladenine in DNA Damage Repair
Zhang, X., Blumenthal, R., & Cheng, X. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.09.007 · Cited by 27
Metadata
- Authors
- Tong, J., Flavell, R. A., & Li, H.-B.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Frontiers of Medicine
- Published
- 2018-08
- Volume
- 12
- Issue
- 4
- Pages
- 481-489
- ISSN
- 1673-7342 (ISSN-L)
- 2095-0217
- 2095-0225
- OpenAlex
- W2885250628
- Cited by
- 233
- References
- 72
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 28 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 45 · 2019: 16 · 2018: 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Frontiers of Medicine (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Natural Science Foundation of China (91753141)
- Shanghai Jiao Tong University
- School of Medicine, Shanghai Jiao Tong University
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- N6-methyladenosine, m6A RNA methylation, post-transcriptional RNA modification, m6A writers, m6A erasers, m6A reader, FTO, ALKBH5, YTH domain proteins, IGF2BP, HNRNPA2B1, eIF3, cancer, human disease, RNA metabolism
- MeSH terms
- Adenosine, Cell Differentiation, Humans, Neoplasms, RNA, RNA Processing, Post-Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review